Stockscreener 앱 받기
13.60
7.09%
0.90
시간 외 거래:
13.65
0.05
+0.37%
전일 마감가:
$12.70
열려 있는:
$12.78
하루 거래량:
4.98M
Relative Volume:
2.06
시가총액:
$2.37B
수익:
$61.10M
순이익/손실:
$-138.36M
주가수익비율:
-10.07
EPS:
-1.35
순현금흐름:
$-90.59M
1주 성능:
+11.38%
1개월 성능:
+13.33%
6개월 성능:
+90.21%
1년 성능:
+61.14%
1일 변동 폭
$12.67
$13.85
1주일 범위
$12.02
$13.85
52주 변동 폭
$5.80
$13.85
Ocular Therapeutix Inc Stock (OCUL) Company Profile
명칭
Ocular Therapeutix Inc
전화
781-357-4000
주소
15 CROSBY DRIVE, BEDFORD, MA
OCUL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
13.60 | 2.21B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-08 | 개시 | William Blair | Outperform |
| 2025-03-18 | 개시 | RBC Capital Mkts | Outperform |
| 2025-03-11 | 개시 | Needham | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-20 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-31 | 재개 | Piper Sandler | Overweight |
| 2024-02-09 | 개시 | BofA Securities | Buy |
| 2023-04-21 | 개시 | Robert W. Baird | Outperform |
| 2022-08-10 | 재개 | Berenberg | Buy |
| 2021-08-10 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-11-13 | 재확인 | Raymond James | Strong Buy |
| 2020-08-10 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-03 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2019-05-21 | 재확인 | H.C. Wainwright | Buy |
| 2019-05-21 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-11-15 | 개시 | Raymond James | Strong Buy |
| 2018-09-07 | 개시 | Piper Jaffray | Overweight |
| 2017-10-24 | 개시 | Guggenheim | Buy |
| 2017-07-26 | 개시 | H.C. Wainwright | Buy |
| 2017-07-12 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-06-23 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2016-11-15 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-08-11 | 개시 | JMP Securities | Mkt Outperform |
| 2016-02-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | 개시 | Morgan Stanley | Overweight |
모두보기
Ocular Therapeutix Inc 주식(OCUL)의 최신 뉴스
Key deals this week: Ocular Therapeutix, CoreWeave, Air Lease, Cadence and more (AL:NYSE) - Seeking Alpha
Best data tools to analyze Ocular Therapeutix Inc. stockWeekly Market Summary & Target Return Focused Stock Picks - Newser
Is Ocular Therapeutix Inc. a candidate for recovery play2025 Key Lessons & AI Forecasted Entry and Exit Points - Newser
Can Ocular Therapeutix Inc. rally from current levelsEarnings Growth Summary & Growth-Oriented Investment Plans - Newser
Can Ocular Therapeutix Inc. disrupt its industryEarnings Summary Report & Real-Time Buy Zone Alerts - خودرو بانک
Signal strength of Ocular Therapeutix Inc. stock in tech scannersTrade Exit Summary & Weekly High Return Forecasts - Newser
Visual trend scoring systems applied to Ocular Therapeutix Inc.July 2025 Snapshot & Daily Profit Maximizing Tips - Newser
What candlestick patterns are forming on Ocular Therapeutix Inc.Trade Volume Report & Real-Time Buy Zone Alerts - Newser
What to do if you’re stuck in Ocular Therapeutix Inc.2025 Buyback Activity & Long Hold Capital Preservation Tips - Newser
Will Ocular Therapeutix Inc. outperform the market in YEAR2025 Buyback Activity & Real-Time Volume Surge Alerts - خودرو بانک
Ocular Therapeutix Shares Rise on Takeover Speculation - AInvest
Ocular Therapeutix gains amid takeover speculation (update) (OCUL:NASDAQ) - Seeking Alpha
Is Ocular Therapeutix Inc. stock bottoming outExit Point & Intraday High Probability Setup Alerts - Newser
Has Ocular Therapeutix Inc. found a price floorTrade Risk Assessment & Low Volatility Stock Suggestions - Newser
How to build a dashboard for Ocular Therapeutix Inc. stockBuy Signal & High Conviction Buy Zone Alerts - Newser
Is Ocular Therapeutix Inc. stock forming a triangle pattern2025 Volatility Report & Growth Focused Stock Reports - خودرو بانک
Ocular Therapeutix's Unusual Options Activity: A Closer Look - AInvest
How to build a custom watchlist for Ocular Therapeutix Inc.Rate Hike & Fast Momentum Stock Entry Tips - Newser
Ocular Therapeutix CEO Donald Notman sells 1066 shares at $12.43/share on Sept 2, 2023. - AInvest
Acute Respiratory Distress Syndrome Market Forecast and - GlobeNewswire
Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - uk.finance.yahoo.com
How hedge fund analytics apply to Ocular Therapeutix Inc. stockMarket Activity Summary & Fast Exit/Entry Strategy Plans - Newser
What are Ocular Therapeutix Inc.’s earnings expectationsQuarterly Portfolio Report & Fast Gain Swing Alerts - خودرو بانک
Will Ocular Therapeutix Inc. outperform the marketPortfolio Risk Summary & Accurate Trade Setup Notifications - Newser
Technical analysis overview for Ocular Therapeutix Inc. stockJuly 2025 Closing Moves & Smart Swing Trading Alerts - Newser
Ocular Therapeutix Inc. stock retracement – recovery analysis2025 Fundamental Recap & Verified Short-Term Plans - Newser
Ocular Therapeutix Inc. stock trend outlook and recovery pathPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - Newser
Backtesting results for Ocular Therapeutix Inc. trading strategiesWeekly Profit Recap & Verified Momentum Watchlists - Newser
Is Ocular Therapeutix Inc. stock poised for growthDollar Strength & Reliable Breakout Forecasts - Newser
Chart based analysis of Ocular Therapeutix Inc. trends2025 Market Overview & Risk Managed Trade Strategies - Newser
How to use a screener to detect Ocular Therapeutix Inc. breakouts2025 Trading Recap & Daily Growth Stock Tips - Newser
Ocular Hypertension Pipeline Insights Report DelveInsight | Santen Pharmaceutical, Nicox Ophthalmics, Inc., Allysta Pharmaceuticals, Qlaris Bio, Inc, Ripple Therapeutics, Laboratoires Thea, Ocular T - The Globe and Mail
Ocular Therapeutix stock hits 52-week high at $12.91 - Investing.com
Sector ETF performance correlation with Ocular Therapeutix Inc.July 2025 Macro Moves & Reliable Price Breakout Signals - Newser
Visual analytics tools that track Ocular Therapeutix Inc. performance2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Does Ocular Therapeutix Inc. stock benefit from AI growthJuly 2025 Spike Watch & Reliable Breakout Forecasts - خودرو بانک
Historical volatility pattern of Ocular Therapeutix Inc. visualizedWeekly Risk Report & Safe Entry Momentum Tips - Newser
Can Ocular Therapeutix Inc. maintain its current growth rate2025 Dividend Review & Technical Entry and Exit Tips - خودرو بانک
Statistical indicators supporting Ocular Therapeutix Inc.’s strengthQuarterly Earnings Report & High Accuracy Trade Alerts - Newser
How much upside does Ocular Therapeutix Inc. haveJuly 2025 Trade Ideas & Safe Swing Trade Setups - خودرو بانک
EURETINA Innovation Spotlight kickstarts the 2025 Congress - Modern Retina
What are Ocular Therapeutix Inc.’s technical support levelsJuly 2025 Technicals & AI Powered Market Entry Ideas - خودرو بانک
Will Ocular Therapeutix Inc. benefit from macro trends2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Is Ocular Therapeutix Inc. currently under institutional pressureEarnings Recap Report & Weekly High Return Stock Opportunities - خودرو بانک
Ocular Therapeutix Inc (OCUL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):